Early phase value scan for biotechnology innovation
نویسندگان
چکیده
منابع مشابه
Clusters and Innovation in Biotechnology
This paper focuses on biotechnology innovation in a peripheral region of Canada. It views the industry sector from a cluster standpoint. The paper presents descriptive data on nine companies and 13 support organizations that have been visited as part of a continuing study. At this point in time, it is not clear whether the collection of organizations in Halifax, Nova Scotia represents a biotech...
متن کاملRelevance of technological innovation and entrepreneurship to biotechnology in Iran
One of the latest and most controversial areas of science is biotechnology. Genetic engineering concerns with the manipulation of DNA molecules to modify plants, animals and other creatures. Scientists are now able to isolate a gene or genome in an animal or plant to another one, based on the traits they want to transfer. The movement of a gene from a living creature to another one is called th...
متن کاملScan of Canadian Strengths in Biotechnology
Science-Metrix specializes in the measurement and evaluation of science, technology and innovation. Our data collection and assessment methods include bibliometrics, scientometrics, technometrics, surveys and interviews, environmental scans, monitoring and intelligence gathering. We perform program and policy evaluations, benchmarking and sector analyses, market studies and strategic planning. ...
متن کاملA New Space for Biotechnology Innovation? Comparison of Physical and Virtual Collaboration in Early Drug Discovery1
New technological opportunities and online communication constantly gain importance for knowledge integration and knowledge creation in any innovation-driven environment. The cooperation between firms and individual actors in biotechnology was characteristically organized in local or regional clusters, based on face-to-face communications and strategic temporary linkages to other clusters. Howe...
متن کاملFrom maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
The pharmaceutical and agro-biotechnology industries have been confronted by dwindling product pipelines and rapid developments in life sciences, thus demanding a strategic rethink of conventional research and development. Despite offering both industries a solution to the pipeline problem, the life sciences have also brought complex regulatory challenges for firms. In this paper, we comment on...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The EuroBiotech Journal
سال: 2017
ISSN: 2564-615X
DOI: 10.24190/issn2564-615x/2017/02.08